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Abstract
Objective: The primary objective of this study was to
ascertain the association of anaerobic bacteria in in-
trapulmonary infections and their susceptibility pat-
tern to commonly prescribed antibiotics. Methods: One
hundred clinical samples (85 broncho-alveolar lavage
and 15 lung abscess aspirates) from suspected intrapul-
monary infection cases were investigated in order to
determine the role of anaerobic bacteria in these infec-
tions. The anaerobic bacterial isolates were identified by
using the Vitek Anaerobic Card System and conventional
methods. Susceptibility of these isolates was deter-
mined by Etest method against eight commonly pre-
scribed antibiotics. Results: A total of 42 anaerobes were
isolated, of which Prevotella spp. were the commonest
isolates, made up of 42.9% (18/42), followed by Pepto-
streptococcus spp. 33.3% (14/42). Only two Bacteroides
fragilis strains were isolated. All the isolates were sensi-
tive to metronidazole, clindamycin, imipenem and mero-
penem; however, one Prevotella was resistant to pipera-
cillin-tazobactam. The two B. fragilis isolates were sus-
ceptible to metronidazole, imipenem, meropenem and
piperacillin-tazobactam, and one was found to be resis-
tant to clindamycin. Conclusion: Overall, Prevotella spp.
were found to be the predominant anaerobic bacteria
associated with intrapulmonary infections in Kuwait. All
the commonly prescribed antibiotics had excellent in
vitro activities against nearly all the isolates.
Copyright © 2001 S. Karger AG, Basel
Introduction
Anaerobic bacteria are recognized causative pathogens
involved in aspiration pneumonia and its suppurative
complications, lung abscess and empyema. In recent
years, with the advent of antibiotics, the bacteriology of
intrapulmonary infections has changed [1]. In the pre-
antibiotic era, Streptococcus pneumoniae was the pre-
dominant causative pathogen of empyema. However,
since the advent of penicillin and other ß-lactam antibiot-
ics, its prevalence in this disease has dropped significantly
to only about 10% of all cases. In its place anaerobes have
now become the major bacterial pathogen associated with
intrapulmonary infections [2–5]. In an earlier study re-
ported by Bartlett et al. [2] anaerobic bacteria were associ-
ated with empyema in 79% of cases studied. Their isolates
included Fusobacterium nucleatum, Bacteroides melani-
nogenicus, Bacteroides fragilis and gram-positive anaero-
bic and microaerophilic cocci in that order of frequency.
After changes in taxonomy of anaerobic bacteria, Marina
et al. [6] retrospectively analysed the results of pleuropul-
monary specimens processed between 1976 and 1993.
They found F. nucleatum, non-pigmented Prevotella,
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Peptostreptococcus and members of the B. fragilis group to
be the prevalent anaerobes associated with intrapulmona-
ry infections. They isolated 3.0 anaerobes per pleural fluid
specimen compared to 2.1 isolates per specimen isolated
by Bartlett et al. [2]. In another retrospective study, Civen
et al. [7] reported similar bacterial isolates from cases of
empyema at a frequency of 3.5 isolates per specimen.
The treatment of patients with intrapulmonary infec-
tion has usually included administration of antibiotics,
supportive care and drainage. Antibiotic selection is sim-
plified when the diagnosis is established by gram staining
and culture identification followed by antimicrobial sus-
ceptibility results [8]. Anaerobes are increasingly becom-
ing resistant to ß-lactams due to ß-lactamase production
and other mechanisms, as reported from different parts of
the world including Kuwait [9, 10]. Quinolones are re-
ported to be inactive or marginally active against anaer-
obes [9]. Recently, Rotimi et al. [11] reported highly
metronidazole-resistant Bacteroides spp. isolated from 3
patients from Kuwait. These reports have made antibiotic
therapy in suspected anaerobic intrapulmonary infections
more complicated. Hence, detailed antimicrobial suscep-
tibility testing must be carried out to guide the proper
antibiotic therapy. In the present study, we report the iso-
lation of anaerobic bacteria associated with intrapulmo-
nary infections in Kuwait as well as their antimicrobial
susceptibility to eight frequently prescribed anti-anaero-
bic antimicrobial agents.
Materials and Methods
A total of 100 intrapulmonary samples, of which 85 were bron-
cho-alveolar lavage (BAL) and 15 aspirated pus from lung abscess,
obtained from 100 patients were investigated over a period of 14
months from July 1997 to September 1998. Their ages ranged from
23 to 58 years with a mean of 42.3 years; 73 were males and 2
females. Fifteen patients had lung abscess as secondary to aspiration
pneumonia. Of the remaining 85 patients, 20 were diagnosed with
lung cancer, 30 were obvious cases of aspiration pneumonia and the
remaining 35 were empyema cases. The samples were collected in
sterile airtight containers and transported to the Anaerobic Laborato-
ry in the Department of Microbiology, Faculty of Medicine within
1 h of collection for immediate processing. In the laboratory, all these
specimens were cultured onto a set of selective and non-selective
media: Brucella agar (Difco, Detroit, Mich., USA) supplemented
with 5% horse blood, vitamin K (10 Ìg/ml), hemin (5 Ìg/ml) and
gentamicin (75 Ìg/ml) and plain Brucella agar plus 5% horse blood
without supplements. A metronidazole disk (5 Ìg) was placed on the
surface of the inoculated agar plates. The plates were then incubated
in the anaerobic jar (Oxoid Ltd., Basingstoke, UK) at 37°C for 48 h
and examined for any growth. All plates without visible growth were
further reincubated for 5 days. Representative colonies were chosen
and subcultured for pure growth and then identified by the Vitek
Anaerobic Card System (bioMerieux, Vitek Inc., Hazelwood, Mo.,
USA) and combined with conventional identification methods [12].
Susceptibility of the anaerobic isolates was determined by esti-
mating the minimum inhibitory concentrations (MICs) of metroni-
dazole, clindamycin, imipenem, meropenem, cefoxitin, cefopera-
zone, ceftizoxime and piperacillin-tazobactam using Etest (AB Strips
Biodisk, Solna, Sweden). Briefly, a suspension of the bacteria was
made in brain-heart infusion broth to meet a 0.5 McFarland turbidi-
ty standard which was then used to inoculate Wilkins-Chalgren agar
(Unipath, Basingstoke, UK) supplemented with 7% horse blood.
Etest strips were then placed on the inoculated plates and incubated
in the anaerobic jars at 37°C for 48 h. The MIC was taken as the
point of interception of the elliptical zone of inhibition across the
strip. Interpretative criteria for susceptibility break points (Ìg/ml)
recommended by the National Committee for Clinical Laboratory
Standards [13] were followed in determining which strain was sensi-
tive or resistant. B. fragilis ATCC 25285 was used in each run as a
control to assess the reliability of the method and antimicrobial
potency. Anaerobiosis was controlled by a nutrient agar plate of Pseu-
domonas aeruginosa and a chemical indicator placed inside each jar.
The MICs less than or equal to the breakpoint were considered sus-
ceptible. Organisms inhibited by MICs greater than the breakpoint
were considered resistant.
Results
A total of 42 anaerobic bacteria were isolated from 100
intrapulmonary samples at an isolation rate of 0.42 organ-
isms per specimen. The aerobic bacterial isolates were S.
pneumoniae, Haemophilus influenzae, and Klebsiella
pneumoniae. Of the anaerobic isolates, Prevotella spp.
were the commonest isolates, representing 42.9% (18/42)
followed by Peptostreptococcus spp., 33.3% (14/42). How-
ever, of the 42 isolates, Peptostreptococcus micros was the
single most common anaerobic species, which accounted
for 14 (33.3%) of all strains. This was followed by Pr.
intermedia, 10 out of 42 (42%), Fusobacterium nuclea-
Table 1. Distribution of anaerobic bacterial
isolates from intrapulmonary samples
Organism Number
(n = 42)
Percent
Prevotella spp.
Pr. intermedia 10 23.8
Pr. melaninogenica 5 11.9
Pr. denticola 3 7.1
Subtotal 18 42.9
P. micros 14 33.3
F. nucleatum 8 19.1
B. fragilis 2 4.8
Total 42 100
Pr. intermedia
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Table 2. Susceptibility pattern of the 42 anaerobic isolates to 8 antimicrobial agents at accepted breakpoints
Organism Percentage of strains susceptible to
strains
tested
metro-
nidazole
clinda-
mycin
imipenem meropenem cefoxitin cefoperazone ceftizoxime piperacillin-
tazobactam
10 100 100 100 100 100 70.0 80.0 90.0
Pr. melaninogenica 5 100 100 100 100 100 60.0 80.0 100
Pr. denticola 3 100 100 100 100 100 66.6 100 100
P. micros 14 100 100 100 100 100 83.3 83.3 83.3
F. nucleatum 8 100 100 100 100 87.5 87.5 100 100
Total 40 100 100 100 100 97.5 74 89.1 95.1
tum, 8 out of 42 (19%), Pr. melaninogenica, 5 out of 42
(12%) and Pr. denticola, 3 out of 42 (7%). Only two strains
of B. fragilis were isolated in this study (table 1).
The susceptibility pattern of the isolates is shown in
table 2. All the Prevotella  and Peptostreptococcus spp.
were susceptible to metronidazole, clindamycin, imipen-
em, meropenem and cefoxitin with MIC90s of 0.5 and
1.0 Ìg/ml, 0.5 and 1.0 Ìg/ml, 0.25 and 0.25 Ìg/ml, 0.25
and 0.25 Ìg/ml, and 4 and 8 Ìg/ml, respectively. Only one
Prevotella and two P. micros were resistant to piperacillin-
tazobactam (MIC 164 Ìg/ml). The F. nucleatum isolates
were susceptible to metronidazole, clindamyin, imipen-
em, meropenem, ceftizoxime and piperacillin-tazobac-
tam with MIC90s of 0.25, 1.0, 0.25, 0.25, 1.5, and 2 Ìg/ml,
respectively. The two isolates of B. fragilis were suscepti-
ble to metronidazole (MIC = 0.5 Ìg/ml) and piperacillin-
tazobactam (MIC = 4 Ìg/ml) and one was resistant to clin-
damycin (MIC = 16 Ìg/ml).
Discussion
Anaerobic bacteria are relatively common in a variety of
pulmonary infections and are especially often involved in
aspiration pneumonia and its complications. Investigation
of such conditions can be problematic because of the meth-
od required to obtain proper specimens, e.g., transthoracic
aspiration is no longer used in general medicine. The alter-
native, open lung biopsy aspiration, is not ethically justi-
fied. However, double-lumen brush border protected BAL
is now commonly used for this purpose as the least danger-
ous of the invasive methods available [14–16].
The most commonly encountered anaerobes in intra-
pulmonary infections reported from the industrialized
countries are the pigmented Prevotella spp. with a pre-
dominance of Prevotella intermedia and Prevotella mela-
ninogenica, non-pigmented Prevotella, spp., F. nuclea-
tum, Peptostreptococcus spp. and Bacteroides spp. [1–3, 6,
7]. Our findings in the present study are essentially similar
to these reports. However, the gram-positive anaerobic
cocci, i.e. P. micros, was the predominant anaerobe in the
intrapulmonary infections studied by us. The isolation
rate of these organisms was 0.43 anaerobe per clinical
specimen. This isolation rate is considerably lower than
that reported by others [2, 7]. A number of factors might
have been responsible for this discrepancy, including the
inevitable delay in transportation of specimens to the lab-
oratory and unavoidable brief exposure to air on the
bench. It is also conceivable that infections other than
those traditionally associated with anaerobic bacteria
were investigated. It is noteworthy that all 15 lung ab-
scesses yielded anaerobes on culture. Finding only 2 iso-
lates of B. fragilis in these infections is consistent with
other reports, which indicate that it does not commonly
occur in intrapulmonary infections, whereas black pig-
mented Prevotella spp. and anaerobic cocci are quantita-
tively and qualitatively predominant.
Antimicrobial agents have played an important role in
the therapy of both aerobic and anaerobic bacterial infec-
tions. In contrast to aerobic bacterial lung infections, few
treatment options are available for anaerobic infections
because of their intrinsic resistance to many antibiotics.
The development of resistance to antimicrobial agents
has made the reporting of susceptibility of anaerobes less
predictable and increased the demand on laboratories to
provide such susceptibility data. Disk diffusion tests for
example are generally not applicable for susceptibility
testing of anaerobes because the gradient profile around
the disk changes over time. A large zone of inhibition may
only reflect slow growth of anaerobes and not their actual
susceptibility. Thus, the Etest, which has been evaluated
by several workers and found suitable for testing anaer-
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obes [17, 18], is the current recommended susceptibility
testing methodology [13]. The agar dilution method can
also be used, but this method is time-consuming and
tedious to perform. In the present study, metronidazole,
clindamycin, imipenem, meropenem and, to some extent,
piperacillin-tazobactam had excellent in vitro activity
against all the isolates at concentrations far below the
achievable serum levels following normal parenteral and
oral dosage of these antibiotics. Cefoxitin, a second gener-
aton cephamycin, and the newer generation cephalospo-
rins, cefoperazone and ceftizoxime, reportedly active
against aerobes, were less active than the traditional drugs
often used for anaerobic infections. Hence, these latter
drugs should be used with caution when considering drugs
for empirical therapy of anaerobic pleuropulmonary in-
fections.
Over the years, most of the anaerobes and particularly
the Bacteroides spp. have displayed remarkable stability
to the in vitro activity of metronidazole, the most widely
used drug against anaerobic infections. However, recently
Rotimi et al. [11] have reported metronidazole-resistant
B. fragilis isolated from intra-abdominal infections from
3 patients in Kuwait. Although the overall resistance rate
in Kuwait is very low, 1% [10], it is therefore important
that the clinical laboratories be alert to potential emer-
gence of resistant strains in their hospitals. The Prevotella
spp., Peptostreptococcus spp. and Fusobacterium spp.
were all sensitive to clindamycin, imipenem and mero-
penem. Similar isolates in an earlier study in Kuwait by
Rotimi et al. [10] also showed similar susceptibility pro-
files for all the above antibiotics except clindamycin. In
their report, 10% of Prevotella spp. and 17% of Fusobac-
terium spp., mainly from intra-abdominal infections and
soft tissue infections, were resistant to clindamycin by the
agar dilution method.
Conclusion
Prevotella spp. were found to be the dominant anaero-
bic bacterial isolates from intrapulmonary infections, but
individually P. micros was the most common isolate.
Metronidazole, a time-tested anti-anaerobic agent, and
the carbapenems had excellent in vitro activity against
anaerobic bacteria. These agents and piperacillin-tazo-
bactam could be used as alternatives to clindamycin,
often used in the treatment of intrapulmonary anaerobic
infections, because of their low MIC values and other out-
standing pharmacokinetic properties.
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